Largest pharmaceuticals by revenue
Everything the company sold in its latest fiscal year, before any cost is taken off.
Johnson & Johnson leads the 52 pharmaceuticals ranked by revenue, at THB 3.2T, ahead of Eli Lilly (THB 2.21T) and Merck & Co (THB 2.21T). Figures as of 18 Nov 2026, 16:15 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 52
- First
- Johnson & JohnsonTHB 3.2T
- Median
- THB 108.7B
- Combined market value
- THB 172.63T
- Countries
- 10
- Not ranked
- 9no revenue on file
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Revenue ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Johnson & JohnsonJNJ · Health Care | THB 3.2T | THB 22.5T | THB 9,347.11 | 1.21% down | 38% up | ||
| 2 | Eli LillyLLY · Health Care | THB 2.21T | THB 42.03T | THB 47,185.07 | 1.82% down | 35% up | ||
| 3 | Merck & CoMRK · Health Care | THB 2.21T | THB 11.69T | THB 4,742.48 | 2.57% down | 51% up | ||
| 4 | PfizerPFE · Health Care | THB 2.12T | THB 5.45T | THB 956.03 | 1.09% down | 14% up | ||
| 5 | AbbVieABBV · Health Care | THB 2.08T | THB 17.31T | THB 9,790.33 | 1.52% down | 26% up | ||
| 6 | AstraZenecaAZN · Health Care | THB 1.99T | THB 9.41T | THB 6,069.58 | 1.91% down | 2% up | ||
| 7 | NovartisNVS · Health Care | THB 1.85T | THB 10.01T | THB 5,301.46 | 1.87% down | 25% up | ||
| 8 | SanofiSNY · Health Care | THB 1.64T | THB 3.86T | THB 1,606.68 | 0.43% down | 4% down | ||
| 9 | Bristol-Myers SquibbBMY · Health Care | THB 1.64T | THB 4.17T | THB 2,038.02 | 2.15% down | 34% up | ||
| 10 | Novo NordiskNVO · Health Care | THB 1.56T | THB 5.94T | THB 1,347.82 | 2.46% down | 17% down | ||
| 11 | Abbott LaboratoriesABT · Health Care | THB 1.5T | THB 6.13T | THB 3,540.99 | 0.39% down | 17% down | ||
| 12 | GSKGSK · Health Care | THB 1.47T | THB 3.32T | THB 1,656.08 | 0.93% down | 6% up | ||
| 13 | Takeda PharmaceuticalTAK · Health Care | THB 958B | THB 2.32T | THB 725.51 | 1.25% down | 54% up | ||
| 14 | Teva Pharmaceutical IndustriesTEVA · Health Care | THB 585.9B | THB 1.67T | THB 1,435.24 | 0.81% down | 74% up | ||
| 15 | Regeneron PharmaceuticalsREGN · Health Care | THB 486.9B | THB 3.35T | THB 32,399.84 | 0.36% down | 36% up | ||
| 16 | ViatrisVTRS · Health Care | THB 485.5B | THB 803.5B | THB 700.90 | 0.95% up | 96% up | ||
| 17 | Vertex PharmaceuticalsVRTX · Health Care | THB 407.4B | THB 4.59T | THB 18,115.72 | 0.11% down | 27% up | ||
| 18 | ZoetisZTS · Health Care | THB 321.4B | THB 1.16T | THB 2,843.65 | 0.34% up | 29% down | ||
| 19 | GrifolsGRFS · Health Care | THB 283.4B | THB 197.2B | THB 289.76 | 1.10% down | 1% up | ||
| 20 | BeOne MedicinesONC · Health Care | THB 181.4B | THB 1.57T | THB 13,708.67 | 2.29% down | 17% up | ||
| 21 | Elanco Animal HealthELAN · Health Care | THB 160.1B | THB 447.2B | THB 894.75 | 1.95% up | 20% up | ||
| 22 | Jazz PharmaceuticalsJAZZ · Health Care | THB 144.9B | THB 530.7B | THB 8,267.67 | 1.17% up | 37% up | ||
| 23 | GenmabGMAB · Health Care | THB 126.3B | THB 1.07T | THB 1,742.99 | 1.19% down | 70% up | ||
| 24 | Alnylam PharmaceuticalsALNY · Health Care | THB 126.1B | THB 694.7B | THB 5,186.88 | 2.38% down | 66% down | ||
| 25 | Dr. Reddy's LaboratoriesRDY · Health Care | THB 121.4B | THB 423.8B | THB 508.40 | 1.25% up | 5% up | ||
| 26 | BioMarin PharmaceuticalBMRN · Health Care | THB 109.4B | THB 394.3B | THB 2,035.47 | 2.47% up | 11% up | ||
| 27 | United TherapeuticsUTHR · Health Care | THB 108.1B | THB 831.6B | THB 19,527.36 | 1.53% down | 23% up | ||
| 28 | Amneal PharmaceuticalsAMRX · Health Care | THB 102.5B | THB 254.9B | THB 731.62 | 2.04% up | 83% up | ||
| 29 | Royalty PharmaRPRX · Health Care | THB 80.7B | THB 1.34T | THB 2,323.47 | 0.35% down | 78% up | ||
| 30 | PTC TherapeuticsPTCT · Health Care | THB 58.8B | THB 170.9B | THB 2,045.83 | 0.17% down | 20% down | ||
| 31 | AlkermesALKS · Health Care | THB 50.1B | THB 266.1B | THB 1,583.26 | 2.61% up | 58% up | ||
| 32 | Legend BiotechLEGN · Health Care | THB 34.9B | THB 107.3B | THB 553.05 | 1.12% up | 42% down | ||
| 33 | Madrigal PharmaceuticalsMDGL · Health Care | THB 32.5B | THB 323.8B | THB 13,937.32 | 2.72% down | 24% down | ||
| 34 | Ionis PharmaceuticalsIONS · Health Care | THB 32B | THB 154.6B | THB 928.19 | 1.41% up | 64% down | ||
| 35 | Arrowhead PharmaceuticalsARWR · Health Care | THB 28.2B | THB 207.7B | THB 1,469.02 | 0.65% up | 10% up | ||
| 36 | Ascendis PharmaASND · Health Care | THB 27.1B | THB 600.7B | THB 9,157.93 | 0.53% down | 28% up | ||
| 37 | Corcept TherapeuticsCORT · Health Care | THB 25.8B | THB 253B | THB 2,312.00 | 2.81% down | 8% down | ||
| 38 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | THB 23B | THB 256.3B | THB 3,262.60 | 1.04% up | 126% up | ||
| 39 | Axsome TherapeuticsAXSM · Health Care | THB 21.7B | THB 238.3B | THB 4,530.63 | 1.84% down | 7% down | ||
| 40 | TG TherapeuticsTGTX · Health Care | THB 20.9B | THB 331.2B | THB 2,191.47 | 2.93% up | 107% up | ||
| 41 | InsmedINSM · Health Care | THB 20.6B | THB 893.8B | THB 4,074.17 | 1.52% down | 40% down | ||
| 42 | Mirum PharmaceuticalsMIRM · Health Care | THB 17.7B | THB 201.9B | THB 3,092.17 | 0.95% down | 31% up | ||
| 43 | BridgeBio PharmaBBIO · Health Care | THB 17B | THB 513.1B | THB 2,633.84 | 1.02% up | 17% up | ||
| 44 | Travere TherapeuticsTVTX · Health Care | THB 16.7B | THB 163.7B | THB 1,705.82 | 1.67% down | 44% up | ||
| 45 | Ligand PharmaceuticalsLGND · Health Care | THB 9.1B | THB 203.3B | THB 10,163.95 | 1.90% up | 43% up | ||
| 46 | Rhythm PharmaceuticalsRYTM · Health Care | THB 6.4B | THB 274.7B | THB 3,961.97 | 0.08% up | 13% up | ||
| 47 | CytokineticsCYTK · Health Care | THB 3B | THB 242B | THB 1,737.56 | 0.91% down | 20% down | ||
| 48 | Protagonist TherapeuticsPTGX · Health Care | THB 1.6B | THB 276B | THB 4,228.13 | 0.10% down | 46% up | ||
| 49 | Roivant SciencesROIV · Health Care | THB 280.4M | THB 953.9B | THB 1,316.58 | 0.18% up | 90% up | ||
| 50 | Dianthus TherapeuticsDNTH · Health Care | THB 69.1M | THB 165.1B | THB 2,932.60 | 0.69% down | 113% up | ||
| 51 | Spyre TherapeuticsSYRE · Health Care | THB 0 | THB 306.9B | THB 3,232.04 | 1.48% up | 286% up | ||
| 52 | Praxis Precision MedicinesPRAX · Health Care | THB 0 | THB 291.8B | THB 10,438.44 | 0.79% up | 61% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Revenue is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 33.9500 THB). 9 companies have no revenue on file and are not ranked here.
Questions and answers
Which pharmaceuticals rank first by revenue?
Johnson & Johnson (THB 3.2T), Eli Lilly (THB 2.21T) and Merck & Co (THB 2.21T) are the top three of the 52 pharmaceuticals ranked by revenue as of 18 Nov 2026, 16:15 UTC.
How many pharmaceuticals are in this ranking?
52 are ranked by revenue. 9 more have no revenue on file and are left out rather than ranked at zero.
What are these pharmaceuticals worth together?
The 52 pharmaceuticals ranked by revenue have a combined market value of THB 172.63T as of 18 Nov 2026, 16:15 UTC.
What does ranking by revenue measure?
Everything the company sold in its latest fiscal year, before any cost is taken off.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Largest pharmaceuticals by revenue”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=revenue
Underlying data: Yahoo Finance; SEC EDGAR.